CARDIOGENIC SHOCK DUE TO VENTRICULAR SEPTAL DEFECT (VSD) AFTER MYOCARDIAL INFARCTION

José Diogo Albuquerque1, Alexandre Caldeira1, Marta Coelho1

  • 1Centro Hospitalar Universitário de Lisboa Norte, Serviço de Anestesiologia, Portugal.

Insights

A 62-year-old man recovered after percutaneous ventricular septal defect (VSD) correction post-myocardial infarction. The procedure led to tricuspid regurgitation, requiring further intervention before stable discharge.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Myocardial infarction can lead to serious complications such as ventricular septal defects (VSDs).
  • Cardiogenic shock following myocardial infarction necessitates urgent intervention.
  • Percutaneous VSD closure is a viable treatment option in select cases.

Observation:

  • A 62-year-old male presented with cardiogenic shock post-myocardial infarction, complicated by a VSD.
  • Intra-aortic balloon pump insertion preceded percutaneous VSD correction.
  • The VSD closure resulted in iatrogenic tricuspid regurgitation.

Findings:

  • Successful percutaneous closure of the VSD was achieved.
  • Iatrogenic tricuspid regurgitation was managed with tricuspid valvuloplasty.
  • Coronary artery bypass grafting (CABG) was performed for underlying stenosis.

Implications:

  • This case highlights the potential complications of percutaneous VSD closure, including tricuspid regurgitation.
  • Multidisciplinary management involving interventional cardiology and cardiac surgery is crucial for complex post-MI cases.
  • Successful management led to patient stabilization and discharge after 26 days.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
76
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
64